IART (Integra) Prakiraan pendapatan perusahaan
Integra LifeSciences (IART) dominates the neurosurgery and regeneration segment, relying on stable demand for consumables to ensure high cash flow. The company's future trading volume exhibits a trend where the indicator value reaches 23.52, confirming a commitment to implementing innovative tissue healing methods. Despite this, the current priority is overcoming temporary product quality challenges to restore its flawless status.
Rincian analitis lan laporan data perusahaan Integra LifeSciences Corp (IART)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Integra LifeSciences|IART - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Integra|IART - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Integra LifeSciences Corp|IART - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Integra LifeSciences|Indikator likuiditas cepet integralife.com
- statistik bathi lan rasio pasar:
IART - Bathi pungkasan|Proyeksi bathi mangsa ngarep Integra LifeSciences|IART - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Integra LifeSciences Holdings Corporation|IART - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Integra LifeSciences Corp|IART - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Integra LifeSciences|IART - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan integralife.com|IART - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Integra LifeSciences
- data dodolan lan asil:
Analisis fundamental perusahaan:Integra LifeSciences
For Integra LifeSciences (IART), the trend in future sales reflects the commercialization potential of patented surgical implants, where high production scalability converts innovation into growing cash flow. This indicator synthesizes expected revenue as a measure of operational efficiency, allowing for an assessment of the cost of capital through the prism of future earnings, although any metric level remains a compromise and does not preclude market drawdowns.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan BSX (Boston Scientific)|EW (edwards.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan ResMed RMD|PODD - Volume dodolan mangsa ngarep perusahaan|Zimmer - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan CooperSurgical|ALGN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GMED|TMDX (TransMedics Group, Inc.) - Prakiraan volume dodolan|Alphatec Holdings (ATEC) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan AORT|Volume dodolan mangsa ngarep perusahaan Enovis Inc. ENOV|Prakiraan volume dodolan ESTA (Establishment Labs)|Prakiraan volume dodolan betabionics.com BBNX|IRMD - Prakiraan pendapatan perusahaan|EMBC: Prakiraan pendapatan perusahaan|TNDM (Tandem Diabetes) - Volume dodolan mangsa ngarep perusahaan|Axogen Surgical - Pendapatan mangsa ngarep perusahaan|SIBN (SI-BONE, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan orthofix.com OFIX|Prakiraan pendapatan perusahaan Bioventus (BVS)|orthopediatrics.com (KIDS) - Prakiraan dodolan perusahaan|Treace Medical - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Strata Medical SRTA|Carlsmed Inc - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan rxsight.com RXST|clearpointneuro.com (CLPT) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan STXS (Stereotaxis Inc)|Prakiraan pendapatan perusahaan NeuroStar|Volume dodolan mangsa ngarep perusahaan Sight Sciences Inc (SGHT)|Prakiraan volume dodolan OBIO|ANIK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan InspireMD NSPR|ZJYL: Prakiraan pendapatan perusahaan|VANI: Volume dodolan mangsa ngarep perusahaan|Xtant Medical Holdings - Prakiraan volume pendapatan perusahaan|NMTC: Prakiraan volume dodolan|MODD - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Myomo|Prakiraan pendapatan perusahaan COCH (Envoy Medical Inc.)|Volume dodolan mangsa ngarep perusahaan VVOS (Vivos Therapeutics, Inc)|Prakiraan volume pendapatan perusahaan NVNO|Prakiraan volume dodolan SINT (Sintx Technologies, Inc.)|tenonmed.com (TNON) - Volume dodolan sing dikarepake perusahaan|Lifeward - Prakiraan volume dodolan|Prakiraan dodolan perusahaan Autonomix Medical, Inc. (AMIX)|INVO Bioscience, Inc. (IVF) - Prakiraan pendapatan perusahaan|Bone Biologics Inc - Pendapatan mangsa ngarep perusahaan|AXNX (Axonics, Inc.) - Prakiraan volume dodolan|Prakiraan volume dodolan biolase.com|Volume dodolan mangsa ngarep perusahaan DYNT (Dynatronics Corporation)|FNA (paragon28.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan INVO Bioscience INVO
